Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LPV/r vs Lamivudine for HIV Prevention in Breastfed Infants (PROMISE-PEP)
NCT00640263Phase 3Completed
- Sponsor
- ANRS
- Start
- Dec 2009
- Primary completion
- May 2013
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 3 trial of lopinavir + ritonavir in human immunodeficiency virus type 1 infection (HIV-1), sponsored by ANRS. Started Dec 2009; status: completed.
02
Drugs
lopinavir + ritonavir
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT00640263.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00640263.